PTHS vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

PTHS

44.8
AI Score
VS
PTHS Wins

NIVF

29.3
AI Score

Investment Advisor Scores

PTHS

45score
Recommendation
HOLD

NIVF

29score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric PTHS NIVF Winner
Forward P/E 0 0.0132 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 11.9% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.8/100 29.3/100 PTHS
Profit Margin -199.5% 209.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

PTHS 1M: -24.2% · 3M: -23.7% NIVF 1M: +102.4% · 3M: +84.3%

Current Technical Phase

PTHS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.8%), weak momentum, RSI 32

RSI (14): 32.4 · Price: $21.90

NIVF

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.3% over 20 days), RSI 60

RSI (14): 59.7 · Price: $1.06

Fundamentals Snapshot

Metric PTHS NIVF
Market Cap
Forward P/E -3.9 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.2%
Operating Margin -1.0% -3.5%
EPS -27.42 328.32
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PTHS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.